Search

Your search keyword '"Maria José Cuadrado"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Maria José Cuadrado" Remove constraint Author: "Maria José Cuadrado"
70 results on '"Maria José Cuadrado"'

Search Results

1. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

2. Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care

3. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

4. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score

6. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

7. Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

8. Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study

9. Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?

10. Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review

11. Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study

12. EULAR recommendations for the management of antiphospholipid syndrome in adults

13. Pregnancy outcomes in mixed connective tissue disease: a multicentre study

14. Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review

15. Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome

16. Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban

17. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome

18. Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study

19. Upcoming biological therapies in systemic lupus erythematosus

20. The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study

21. Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials

22. Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies

23. Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: A randomized, placebo-controlled trial

24. 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report

25. Thrombotic Risk Assessment in Systemic Lupus Erythematosus: Validation of the Global Antiphospholipid Syndrome Score in a Prospective Cohort

26. Use of Intravenous Immunoglobulin in Patients With Active Vasculitis Associated With Concomitant Infection

27. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)

28. Systemic Lupus Erythematosus: Clinical Aspects

29. Emerging therapies in systemic lupus erythematous: From clinical trial to the real life

30. Potential Use of Statins in the Treatment of Antiphospholipid Syndrome

31. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies

32. The estimated frequency of Antiphospholipid antibodies in young adults with cerebrovascular events: A systematic review

33. Long-Term Follow-Up in 128 Patients With Primary Antiphospholipid Syndrome

34. Central nervous system involvement in the antiphospholipid (Hughes) syndrome

35. Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (hughes syndrome)

36. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

37. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends

38. Renal involvement in antiphospholipid syndrome

39. HUGHES (ANTIPHOSPHOLIPID) SYNDROME

40. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy

41. The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects

42. The Future Potential of Biosimilars Targeting B-Cells

43. Management of infection in systemic lupus erythematosus

44. The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

45. Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment

46. Catastrophic antiphospholipid syndrome (CAPS)

47. Catastrophic Antiphospholipid Syndrome

48. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

49. Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome

50. Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches

Catalog

Books, media, physical & digital resources